TEM — Tempus AI Inc
NASDAQ · Life Sciences Tools & Services · Life Sciences Tools & Services
- Latest Close
- $55.15
- 30-Day Move
- -19.7%
- Market Cap
- $8.4B
- Shares Outstanding
- 178,770,000
- P/B Ratio
- 21.38
- ROE
- -49.9%
Tempus AI Inc
A read-only Alphactor snapshot forTempus AI Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-21
Topline snapshot
Latest Close
$55.15
30-Day Move
-19.7%
Market Cap
$8.4B
Shares Outstanding
178,770,000
P/B Ratio
21.38
ROE
-49.9%
$55.15
-19.7%last 90 delayed daily bars
90D High
$76.33
90D Low
$41.73
Avg Volume
5,289,799
Gross margin is running at 62.7%, which gives a quick read on operating quality before you open the full model.
Net margin is -19.3%, useful for comparing TEM against peers in Life Sciences Tools & Services.
TEM is down 19.7% over the last 30 trading days shown on this page.
Latest operating income is $-61M, which helps anchor the headline ratios with an actual earnings figure.
Composite Fair Value
$31.53
Rule of 40
64.1%
Latest Close
$55.15
30-Day Move
-19.7%
Market Cap
$8.4B
Shares Outstanding
178,770,000
P/B Ratio
21.38
ROE
-49.9%
ROA
-10.8%
Gross Margin
62.7%
Operating Margin
-20.8%
Net Margin
-19.3%
Debt / Equity
2.52
Current Ratio
3.13
Latest Revenue
$367M
Revenue
$367M
Gross Profit
$238M
Operating Income
$-61M
Net Income
$-54M
Gross Margin
6274.0%
Net Margin
-1927.0%
Current Ratio
3.13
Debt / Equity
2.52
Fair Value
$31.53
Upside / Downside
-42.8%
Signal
Overvalued
Implied Growth
--
EV/Rev
$31.53
Growth Assumption
50.0%
Discount Rate
9.9%
Terminal Growth
2.0%
Base FCF
--
Valuation spread
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Negative FCF — company is cash-flow negative. Reverse DCF requires positive cash flows.
Altman Z
1.95
Grey
Piotroski
4
Moderate (4-6)
Cash Conversion
0.89x
Rule of 40
64.1%
Elite
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $321M | $-265M | $-290M | $-187M |
| 2023-12-31 | $532M | $-196M | $-214M | $-249M |
| 2024-12-31 | $693M | $-691M | $-706M | $-211M |
| 2025-12-31 | $1.3B | $-253M | $-245M | $-245M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| ARK ETF Trust-ARK Innovation ETF | 6,430,124 | 0.04% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3,536,561 | 0.02% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2,548,825 | 0.01% | 2025-12-31 |
| VANGUARD WORLD FUND-Vanguard U.S. Growth Fund | 2,149,394 | 0.01% | 2025-11-30 |
| ARK ETF Trust-ARK Genomic Revolution ETF | 1,855,783 | 0.01% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1,439,318 | 0.01% | 2025-12-31 |
| BlackRock ETF Trust-iShares A.I. Innovation and Tech Active ETF | 1,115,958 | 0.01% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1,099,941 | 0.01% | 2025-12-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Qube Research & Technologies
Filed 2025-05-15
--
--
Coatue Management
Filed 2025-08-14
--
--
Two Sigma Advisers
Filed 2025-05-15
--
--
Vanguard Group
Filed 2025-11-07
$762M
+22.1%
ARK Investment Management
Filed 2025-11-12
$579M
--
Geode Capital Management
Filed 2025-11-12
$140M
+166.2%
D.E. Shaw
Filed 2026-02-17
$138M
-56.9%
Goldman Sachs
Filed 2026-02-10
$121M
+24.6%
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.